Deutsche Bank Raises Centene (CNC) PT to $39 While Maintaining Hold Rating

Centene Corporation (NYSE:CNC) is one of the best stocks under $50 to invest in. On February 10, Deutsche Bank raised its price target for Centene from $32 to $39 while keeping a Hold rating on the shares. The firm noted that the shares had previously been caught in a downward trend affecting its industry peers.

Earlier on February 6, Centene Corporation (NYSE:CNC) reported its Q4 2025 earnings report, where the company’s diluted loss totaled $1.19 per share, though full-year adjusted EPS of $2.08 slightly exceeded expectations. Total premium and service revenue for 2025 reached $174.6 billion, supported by a Medicaid membership of 12.5 million and a year-end medical claims liability of $20.5 billion.

Looking ahead to 2026, Centene issued revenue guidance of $170 to $174 billion and expects adjusted EPS to grow by over 40% to more than $3. Management anticipates meaningful margin recovery in the ACA marketplace, where membership is projected to hit 3.5 million, and continues to move toward a breakeven point in Medicare Advantage. Despite a projected 5% to 6% decline in Medicaid membership and pressure on 2027 Medicare rates, the firm expressed confidence in its 2026 outlook.

Centene Corporation (NYSE:CNC) operates as a healthcare enterprise that provides programs and services to underinsured & uninsured families and commercial organizations in the US.

While we acknowledge the potential of CNC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.